Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study

PloS One
Weiyuan WuYingxia Liu

Abstract

The prevalence of carbapenem-resistant Acinetobacter baumannii in hospitals has been increasing worldwide. This study aims to investigate the carbapenemase genes and the clonal relatedness among A. baumannii clinical isolates in a Chinese hospital. Carbapenemase genes and the upstream locations of insertion sequences were detected by polymerase chain reaction (PCR), and the clonal relatedness of isolates was determined by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing. A total of 231 nonduplicate carbapenemase gene-harboring A. baumannii clinical isolates recovered from Shenzhen People's Hospital, were investigated between 2002 and 2009. blaOXA-23-like, blaOXA-58-like, blaOXA-40-like, and ISAba1-blaOXA-51-like were identified in 119, 107, 1, and 4 isolates, respectively. IS1008-ΔISAba3, ISAba3, and ISAba1 were detected upstream of the blaOXA-58-like gene in 69, 35, and 3 isolates, respectively. All blaOXA-23-like genes but one had an upstream insertion of ISAba1. blaOXA-58-like was the most common carbapenemase gene in A.baumannii before 2008, thereafter blaOXA-23-like became rapidly prevalent and replaced blaOXA-58-like in 2009. The majority of blaOXA-58-like-carrying isolates showed lower level of resi...Continue Reading

References

Sep 10, 2004·The Journal of Antimicrobial Chemotherapy·Paul G HigginsHarald Seifert
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Claire HéritierPatrice Nordmann
Sep 8, 2005·Journal of Clinical Microbiology·Sergio G BartualFrancisco Rodríguez-Valera
Jan 27, 2006·Antimicrobial Agents and Chemotherapy·Juliana CoelhoDavid Livermore
Mar 28, 2006·International Journal of Antimicrobial Agents·Neil WoodfordDavid M Livermore
Apr 25, 2006·FEMS Microbiology Letters·Jane F TurtonTyrone L Pitt
Aug 3, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L Poirel, P Nordmann
Dec 23, 2006·The Journal of Antimicrobial Chemotherapy·Matthew J EllingtonNeil Woodford
Jan 16, 2007·Antimicrobial Agents and Chemotherapy·Stéphane CorvecPatrice Nordmann
Apr 18, 2007·Antimicrobial Agents and Chemotherapy·Alessia BertiniAlessandra Carattoli
Oct 19, 2007·Journal of Clinical Microbiology·Hua ZhouLan-Juan Li
Sep 2, 2009·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Dec 25, 2009·Emerging Infectious Diseases·Pauline D MugnierPatrice Nordmann
Dec 30, 2009·Antimicrobial Agents and Chemotherapy·Iraida E RobledoGuillermo J Vázquez
Jun 15, 2010·The Journal of Antimicrobial Chemotherapy·B A EvansS G B Amyes
Feb 27, 2013·Antimicrobial Agents and Chemotherapy·Paul G HigginsHarald Seifert

❮ Previous
Next ❯

Citations

Dec 16, 2016·Clinical Microbiology Reviews·Darren WongBrad Spellberg

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
PCR

Software Mentioned

Basic Local Alignment Search Tool
Fingerprint II

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Protein Structures

Bacterial protein structures can expedite the development of novel antibiotics. Here is the latest research on bacterial proteins and the resolution of their structures.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.